Current Evidence Level Stating the evidence tier precisely, without softening: Weighing the positive and negative studies The positive human evidence is real but structurally weak, and the weakness is specific: nearly all of it comes from a single investigator group
Research interest includes connective-tissue research models, angiogenesis-pathway studies, and inflammation-marker investigations
It does that by exerting action on the growth hormone-releasing hormone receptor (GHRH) to release growth hormone in a more stable, sustained manner over time, unlike other peptides, which would cause a transient, rapid burst of release
Number of people with glaucoma worldwide
For more peptide comparisons, read our blogs about sermorelin vs hexarelin, sermorelin vs CJC-1295, sermorelin vs ipamorelin, tesamorelin vs IGF-1 LR3 or tesamorelin vs sermorelin.
The primary contenders are valproic acid, fosphenytoin, or lacosamide